CHE dividend history

CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on March 13, 2026, to shareholders of record as of February 23, 2026. This is equal to the dividend paid in December 2025. This represents the 219th consecutive quarterly dividend

CINCINNATI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This is equal to the dividend paid in August 2025. This represents the 218th consecutive quarterly dividend paid by Chemed in its 54 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hos

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These shares repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on August 29, 2025, to shareholders of record as of August 11, 2025. This is a 10-cent, or 20.0%, increase over the 50-cent dividend paid in June 2025. The previous increase was in August 2024, when the Board raised the quar

Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 50 cents per share on the Company's capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed's

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company's capital stock, payable on March 14, 2025, to shareholders of record as of February 24, 2025. This is equal to the dividend paid in December 2024. This represents the 215th consecutive quarterly dividend paid by Chemed in its 53 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's lead

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company's capital stock, payable on December 6, 2024, to shareholders of record as of November 18, 2024. This is equal to the dividend paid in August 2024. This represents the 214th consecutive quarterly dividend paid by Chemed in its 53 years as a public com

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company's capital stock, payable on August 30, 2024, to shareholders of record as of August 12, 2024. This is a 10-cent, or 25.0%, increase over the 40-cent dividend paid in June 2024. The previous increase was in August 2023, when the Board raised the quarterly dividend from 38-cents to 40-cents per share. This represents the 213th consecutive quarterly dividend paid by Chemed in its 53 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owne

Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2024 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2024. Stockholders also approved Chemed's executive compensation. In addition, stockholders voted against the stockholder proposal on ratification of termination pay. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 40 cents per share on the Company's capital stock, payable on June 18, 2024, to stockholders of record as of May 30, 2024. This represents the 212th consec

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company's capital stock, payable on March 15, 2024, to shareholders of record as of February 26, 2024. This is equal to the dividend paid in December 2023. This represents the 211th consecutive quarterly dividend paid by Chemed in its 52 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's lead

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company's capital stock, payable on December 4, 2023, to shareholders of record as of November 13, 2023. This is equal to the dividend paid in September 2023. This represents the 210th consecutive quarterly dividend paid by Chemed in its 52 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's l

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company's capital stock, payable on September 5, 2023, to shareholders of record as of August 14, 2023. This is a 2-cent, or 5.3%, increase over the 38-cent dividend paid in June 2023. The previous increase was in August 2022, when the Board raised the quarterly dividend from 36-cents to 38-cents per share. This represents the 209th consecutive quarterly dividend paid by Chemed in its 52 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owne

Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2023 annual stockholders' meeting. New to the Board is Eileen McCarthy, Senior Vice President of UiPath, Inc. (NYSE:PATH). Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2023. Stockholders also approved Chemed's executive compensation and recommended the say-on-pay vote remain an annual vote. In addition, stockholders voted against the stockholder proposal on ratification of termination pay. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 38 cents

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 38-cents per share on the Company's capital stock, payable on March 17, 2023, to shareholders of record as of February 27, 2023. This is equal to the dividend paid in December 2022. This represents the 207th consecutive quarterly dividend paid by Chemed in its 50 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's leadi

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 38-cents per share on the Company's capital stock, payable on December 5, 2022, to shareholders of record as of November 14, 2022. This is equal to the dividend paid in September 2022. This represents the 206th consecutive quarterly dividend paid by Chemed in its 51 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's le

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 38-cents per share on the Company's capital stock, payable on September 2, 2022, to shareholders of record as of August 15, 2022. This is a 2-cent, or 5.6%, increase over the 36-cent dividend paid in June 2022. The previous increase was in August 2021, when the Board raised the quarterly dividend from 34-cents to 36-cents per share. This represents the 205th consecutive quarterly dividend paid by Chemed in its 51 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned

Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2022 annual stockholders' meeting. Each of the directors continues from the prior term. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2022. Shareholders also approved Chemed's executive compensation and the 2022 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 36 cents per share on the Company's capital stock, payable on June 15, 2022, to stockholders of record as of May 26, 2022. This represents the 204th consecutive quarterly d

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company's capital stock, payable on March 18, 2022, to shareholders of record as of February 28, 2022. This is equal to the dividend paid in December 2021. This represents the 203rd consecutive quarterly dividend paid by Chemed in its 50 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's leadi

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company's capital stock, payable on December 6, 2021, to shareholders of record as of November 15, 2021. This is equal to the dividend paid in September 2021. This represents the 202nd consecutive quarterly dividend paid by Chemed in its 50 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's le

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company's capital stock, payable on September 2, 2021, to shareholders of record as of August 16, 2021. This is a 2-cent, or 5.9%, increase over the 34-cent dividend paid in June 2021. The previous dividend increase was in August 2020, when the Board raised the quarterly dividend from 32-cents to 34-cents per share. This represents the 201st consecutive quarterly dividend paid by Chemed in its 50 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two who

Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2021 annual stockholders' meeting. Each of the directors continues from the prior term. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2021 and approved Chemed's executive compensation. In addition, stockholders voted in favor of the proposal to issue a semi-annual report on the Company's policies on political spending and political contributions made. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 34 cents per share on the Company's capital stock, p

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2021, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 2.2% to $527 million GAAP Diluted Earnings-per-Share (EPS) of $4.01, an increase of 18.6% Adjusted Diluted EPS of $4.44, an increase of 20.7% VITAS segment operating results: Net Patient Revenue of $316 million, a decline of 6.5% Average Daily Cens

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2020, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 2.1% to $533 million GAAP Diluted Earnings-per-Share (EPS) of $6.96, an increase of 75.8% Adjusted Diluted EPS of $5.13, an increase of 21.6% VITAS segment operating results: Net Patient Revenue of $332 milli

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 34-cents per share on the Company’s capital stock, payable on March 19, 2021, to shareholders of record as of March 1, 2021. This is equal to the dividend paid in December 2020. This represents the 199th consecutive quarterly dividend paid by Chemed in its 49 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and